Ent-16β,17-Dihydroxykauran-19-oic acid
Ent-16β,17-Dihydroxykauran-19-oic acid is an anti-inflammatory agent, which can be isolated from Siegesbeckia pubescens herb. ent-16β,17-Dihydroxykauran-19-oic acid inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglia[1].
Product Specifications
CAS Number
3301-61-9
UNSPSC
12352211
Target
Others
Type
Natural Products
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ent-16β-17-dihydroxykauran-19-oic-acid.html
Purity
98.0
Solubility
10 mM in DMSO
Smiles
C[C@]12[C@@]3([H])[C@]4(CC[C@]1([H])[C@@](C)(CCC2)C(O)=O)C[C@@](O)([C@@](CC3)([H])C4)CO
Molecular Formula
C20H32O4
Molecular Weight
336.47
References & Citations
[1]Lee M, et al. ent-kaurane and ent-pimarane diterpenes from Siegesbeckia pubescens inhibit lipopolysaccharide-induced nitric oxide production in BV2 microglia. Biol Pharm Bull. 2014;37 (1) :152-7.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471081-500 1x 500 µL
CD45RO (190-2F2.5), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040040-100 1x 100 µL
CD35 / CR1 (E11), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040008-100 1x 100 µL
MAGE A1 (MA454), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471238-500 1x 500 µL
Napsin-A (NAPSA/1238), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details